Guardant Health, Inc. (GH) vs Revvity Inc. (RVTY)
Guardant Health, Inc. and Revvity Inc. are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $23.9B against $16.8B — 1.4× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Revvity Inc. trades at 72.0×. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against 4.05%. Revvity Inc. has the higher net margin (8.16% vs −38.3%) and the higher return on invested capital (2.38% vs −129.7%). Across the 18 metrics below, Guardant Health, Inc. leads on 9 and Revvity Inc. on 9.
Valuation
Profitability
| Metric | GH | RVTY | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.01% | 54.98% | 50.89% |
| Operating margin | (39.75%) | 12.32% | (8.57%) |
| Net margin | (38.33%) | 8.16% | (6.37%) |
| Free cash flow margin | (20.35%) | 19.58% | 0.00% |
| Return on equity | 171.64% | 3.21% | (2.92%) |
| Return on assets | (27.95%) | 1.95% | (6.71%) |
| Return on invested capital | (129.70%) | 2.38% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack